Business Wire

GIANT Protocol Publishes Litepaper for Decentralized Internet Connectivity Economy

Share

GIANT Protocol, a leading-edge web3 protocol building a decentralized connectivity economy, today announced the release of its Litepaper, laying out the various components of GIANT Protocol’s ambitious proposal to decentralize and democratize access to the internet and financial services through a web3 telecommunications layer. GIANT plans to roll out the first iteration of its mainnet in the first half of 2022, so the publication of the Litepaper marks a critical step in ensuring GIANT Protocol’s commitment to being an open-source, public protocol built to support a globally connected world.

GIANT Protocol made its debut in November 2021, announcing its intention to build a tokenized bandwidth platform that will allow anyone with a mobile phone to access the internet and earn rewards based on their connectivity. With a founding team well-established in the telecom sector, GIANT Protocol intends to leverage existing network providers, allowing it to rapidly scale its network.

In December 2021, GIANT Protocol announced it had successfully raised $5 million in a seed funding round led by leading blockchain investment firm CoinFund. Now, the project is pleased to build on this progress with the publication of the Litepaper.

The Litepaper was co-authored by Suruchi Gupta, Founder, and CEO of Giant Protocol, along with the GIANT team. Speaking of its publication, Ms. Gupta commented: “The GIANT Litepaper lays out in detail the context and strategy for building a global telecommunications network that can deliver the benefits of web3 to everyone. We want it to convey our ultimate vision for GIANT: to make internet access more than a boring utility, transforming it into an exciting opportunity for better, faster, and more accessible internet access and accompanying financialization potential.”

Along with contextualizing the need for a global decentralized connectivity economy, the Litepaper provides an overview of GIANT’s proposal for its core connectivity infrastructure. It also outlines the GIANT tokenomic model and explains the DAO governance structure that will manage the protocol, including the role of the GIANT Protocol Foundation, a non-profit organization dedicated to supporting the protocol.

Finally, it shows what to expect from the first implementation of the GIANT Protocol – a wallet, a consumer software for end users to interact with GIANT, a provider software for network providers to offer internet access via GIANT, and a validator node software.

GIANT Protocol now invites feedback on the Litepaper from interested stakeholders who wish to be involved in the development and adoption of the GIANT Protocol, whether they’re network owners, developers, or data consumers.

To view the Litepaper, please visit https://giantprotocol.org/litepaper/

About GIANT Protocol

GIANT Protocol was founded in 2021 to decentralize and democratize access to the internet and financial services by tokenizing bandwidth. The project partners with telecommunications and connectivity providers across the globe to create a decentralized connectivity economy, allowing anyone with a mobile phone to participate.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For media enquiries:
Orlagh Lyons
Giant@cw8-communications.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye